RBB Bancorp Looks Cheap at 11.5x Earnings-But 3.06% NIM Is Testing the Growth Story

Q2 Beat Improved Timing, Not Full Confidence

RBB delivered another EPS beat, but the quarter also exposed fresh pressure on profitability.

RBB posted $0.59 diluted EPS versus a $0.53 estimate, so the headline was solid. The sequence, though, worsened: net income fell to $10.1 million from $11.3 million in Q1, return on average assets declined to 0.97% from 1.09%, and net interest margin narrowed to 3.06% from 3.15%. Revenue of $33.1 million was essentially in line with forecasts, so this was a mixed report rather than a top-line setback. For growth-focused investors, that is frustrating: good enough to buy time, not enough to restore full conviction.

The bullish case is easy to see. Net income was still up 13% from a year earlier, and management highlighted strong loan originations and disciplined loan growth. But the market tended to focus on the sequential turn. For banks, margins and returns often matter more in the moment than year-over-year resilience.

That caution showed up right away. Shares traded at $26.31, down 1.61% from the previous close. The reaction looked less like panic than a refusal to reward a beat when earnings quality clearly weakened.

RBB's Growth Narrative Still Has Operating Support

The post-quarter question is not whether RBB produced a clean report. It did not. The question is whether one disappointing quarter should override a still-intact growth framework.

Credit and funding trends are improving even as NIM slipped

The most important counterweight to the weak margin print is that credit stress appears to be easing. Nonperforming assets fell 10.8% to $43.6 million, bringing NPAs to 1.02% of total assets, while non-performing loans declined 47%. That matters because a banking growth story only holds if management can keep resolving existing exposures while continuing to originate new business.

Funding is also improving. Management expanded non-interest-bearing deposits to 17.5% of total deposits, which helps flexibility even in intense deposit competition.

Part of the Q2 margin squeeze also had a more specific cause. According to the earnings summary, the pressure included the repricing of $120 million in subordinated debt from a 4% fixed rate to a 6.98% floating rate, while the official release said net interest income was weighed down in part by the loss of a special Federal Home Loan Bank dividend. That makes the quarter look more like a temporary earnings hit than clear evidence of a broken franchise.

Management still has a credible recovery path

This is not a case built on hope alone. RBB reported strong loan originations and continued growth in retail deposits supported another quarter of solid profitability, and management expects mid-to-high single-digit range for the full year loan growth. It also expects net interest margin to improve in the second half of 2026, aided in part by the $40 million sub-debt redemption.

Those are the operating supports that keep the growth story alive. The recent earnings decline was real, but it does not yet prove that the underlying framework has broken.

Valuation and the Next Few Catalysts

The opportunity here is not a heroic next quarter. It is the gap between where RBB trades and what the market already expects. At 11.47x earnings with trailing EPS of $2.36, the stock is not expensive relative to consensus expectations for $2.51 next-year EPS and 6.36% earnings growth. Investors do not need dramatic acceleration; they need evidence that the recent earnings wobble is a setback rather than a new baseline.

What the market needs to see next

Management has already started addressing the funding pressure that helped compress margins. It announced a common stock repurchase plan for up to 1 million shares through June 30, 2028, and it completed a $40 million partial redemption of subordinated notes on July 1, 2026. Combined with the outlook for NIM improvement in the second half of 2026, that gives investors a tangible recovery path to monitor.

What to watch in the next update

• Capital deployment: Whether the buyback begins to support per-share metrics if organic earnings growth stays moderate.
• Funding costs: Whether the subordinated-note redemption translates into firmer margin commentary.
• Loan growth: Whether originations and pipeline commentary remain consistent with mid-to-high single-digit range for the full year growth.
• Credit trends: Whether improvement continues after nonperforming assets fell 10.8% to $43.6 million.
• Guidance credibility: Whether management still points toward second-half margin recovery rather than another step-down.

If those watchpoints hold, the current discount may look too harsh. If they deteriorate, the 11.47x earnings valuation may simply be reflecting a slower, more pressured earnings profile.